Levofloxacin or Clarithromycin-based quadruple regimens: what is the best alternative as first-line treatment for Helicobacter pylori eradication in a country with high resistance rates for both antibiotics?

BACKGROUND: Helicobacter pylori eradication rates in Portugal are declining, due to increased resistance of this bacterium to antimicrobial agents, especially Clarithromycin. Quadruple Levofloxacin-containing regimens could be an option for first-line treatment, but its efficacy should be evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales: Branquinho, Diogo, Almeida, Nuno, Gregório, Carlos, Cabral, José Eduardo Pina, Casela, Adriano, Donato, Maria Manuel, Tomé, Luís
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312567/
https://www.ncbi.nlm.nih.gov/pubmed/28202013
http://dx.doi.org/10.1186/s12876-017-0589-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312567/
https://www.ncbi.nlm.nih.gov/pubmed/28202013
http://dx.doi.org/10.1186/s12876-017-0589-6

Ejemplares similares